Bacterian pneumonias as a risk marker of new bacterian diseases in patients with HIV infection;Neumonias bacterianas como marcador de riesgo de nuevas enfermedades bacterianas en pacientes infectados por el HIV

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 14, Issue 6, 1996, Pages 361-366

  Teira, Ramón ^a   Virosta, Manuel ^a   Zubero, Zuriñe ^a   Baraia Etxaburu, Josu ^a   Muñoz, Josefa ^a   Cisterna, Ramón ^a   Santamaría, Juan Miguel ^a  

^a HOSPITAL DE BASURTO   (Spain)

Author keywords

Bacterial pneumonia; HIV infection; Prognosis

Indexed keywords

ADULT; ARTICLE; BACTERIAL PNEUMONIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RISK ASSESSMENT; SUPERINFECTION; SURVIVAL TIME; ADOLESCENT; BACTERIAL INFECTION; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RISK FACTOR; SPAIN;

ANTIVIRUS AGENT; ZIDOVUDINE;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; BACTERIAL INFECTIONS; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA, BACTERIAL; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN; ZIDOVUDINE;

EID: 0029664834     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Fauci AS. Immunopathogenesis of HIV Infection. J Acquir Immune Defic Syndr 1993; 6: 655-662.
2. Lane HC, Fauci AS. Immunologic abnormalities in the acquired immunodeficiency syndrome. Ann Rev Immunol 1985; 3: 477-500.
3. Amman AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, Conant M. B-cell immunodeficiency in the acquired immunodeficiency syndrome. JAMA 1984; 251: 1.447-1.449.
4. Simberkoff MS, El Sadr W, Schiffman G, Rahal JJ. Streptococcus pneumoniae infections and bacteremia in patients with acquired immunedeficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis 1984; 130: 1.174-1.176.
5. Polsky B, Gold JWM, Whimbey E, Dryjanski J, Brown AE, Schiffman G et al. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104: 38-41.
6. Selwyn PA, Feingold AR, Hartel D, Schoenbaum EE, Alderman MH, Klein RS et al. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS 1988; 2: 267-272.
7. Chave JP, Bille J, Glauser MP, Francioli P. Diagnosis of pulmonary infections in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1989; 8: 123-126.
8. Magnenat JL, Nicod LP, Auckenthaler R, Junod AF. Mode of presentation and diagnosis of bacterial pneumonia in human immunodeficiency virus-infected patients. Am Rev Respir Dis 1991; 144; 917-922.
9. Willocks L, Cowan F, Brettle RP, Emmanuel FXS, Flegg PJ, Burns S. The spectrum of chest infections in HIV positive patients in Edinburgh. J Infect 1992; 24: 37-42.
10. Teira R, Zubero Z, Muñoz J, Álvarez M, Cisterna R, Santamaría JM. Neumonías por bacterias no oportunistas en pacientes infectados por el VIH. Incidencia y valoración de una aproximación no invasiva. Enferm Infecc Microbiol Clin 1992; 10: 11-16.
11. Farizo KA, Buehler JW, Chamberland ME, Whyte BM, Froelicher ES, Hopkins SG et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992; 267: 1.798-1.805.
12. Mientjes GH, van Ameijden EJ, Weigel HM, van den Hoek JA, Coutinho RA. Clinical symptoms associated with seroconversion for HIV-1 among misusers of intravenous drugs: comparison with homosexual seroconverters and non-infected drug misusers. BMJ 1993; 306: 371-373.
13. Selwyn PA, Alcabes P, Hartel D, Buono D, Schoenbaum EE, Klein RE et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992; 327: 1.697-1.703.
14. 1993 Revised classification system for HIV infection and expanded case definition for AIDS among adolescent and adults. MMWR Morbid Mortal Wkly Rep 1992; 41: 1-19.
15. WHO-EC Collaborating Centre on AIDS. AIDS surveillance in Europe. Quarterly Report n.' 37, 1993.
16. Teira R, Virosta M, Muñoz J, Zubero Z, Baraia-Etxaburu J, Santamaría JM. Bacterial penumonias as a marker of disease progression [resumen PBO552, p 135]. International Conference on AIDS. International Conference on STD. Yokohama, 1994. Libra de resúmenes, vol. 2.
17. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987; 36 Supl 1: 1-15.
18. Análisis de la supervivencia. En: Armitage P, Berry G, eds. Estadística para la investigación biomédica. Barcelona: Ediciones Doyma S.A., 1992; 493-515.
19. Measures of effect for crude analysis. En: Ahlbom A, ed. Biostatistics for epidemiologists. Boca Raton: Lewis Publishers, 1993; 61-84.
20. Medidas de asociación. Medidas de impacto. En: Argimón JM, Jiménez J, eds. Métodos de investigación. Barcelona: Ediciones Doyma S.A., 1991; 213-218.
21. Doménech JM, Sarriá A. Modelo de regresión de Cox. En: Doménech JM, ed. Análisis multivariante en ciencias de la salud. Barcelona: Gráficas Signo, 1993; 12: 3-43.
22. Esposito AL. Community-acquired bacteremic pneumococcal pneumonia. Effect of age on manifestations and outcome. Arch Intern Med 1984; 144: 945-948.
23. Burman LA, Norrby R, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 1985; 7: 133-142.
24. Redd SC, Rutherford III GW, Sande MA, Lifson AR, Hadley WK, Facklam RR et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990; 162: 1.012-1.027.
25. Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med 1992; 327: 1.842-1.848.
26. Nichols L, Balogh K, Silverman M. Bacterial infections in the acquired immunedeficiency syndrome. Clinicopathologic correlations in a series of autopsy cases. Am J Clin Pathol 1989; 92: 787-790.
27. Teira R, Zubero Z. Consideraciones sobre la clasificación de la infecciôn por el VIH. Med Clin (Bare) 1993; 100: 120.